New Enterprise Associates
American Venture Capital firm
Follow New Enterprise Associates on Notably News to receive short updates to your email — rarely!
| 2025 | NEA maintains a diverse investment portfolio of 370 portfolio companies, spanning technology, healthcare, robotics, media, and various innovative sectors. |
| July 17 2025 | New Enterprise Associates (NEA) is actively investing in multiple companies across various sectors, including pharmaceuticals (Acadia Pharmaceuticals, Alimera Sciences, Amicus Therapeutics, Clovis Oncology), technology (Databricks), and biotechnology (Adaptimmune, Prosensa, Tesaro). |
| 2018 | Jeff Immelt, former CEO of General Electric, joined New Enterprise Associates (NEA) as a venture partner, expanding the firm's leadership and strategic capabilities. |
| 2012 | NEA invested over $14 billion in venture capital across nearly 50 biopharma companies through 14 funds. |
This contents of the box above is based on material from the Wikipedia article New Enterprise Associates, which is released under the Creative Commons Attribution-ShareAlike 4.0 International License.